Optical coherence tomography confirms non‐malignant pigmented lesions in phacomatosis pigmentokeratotica using a support vector machine learning algorithm
Skin Research and Technology · 2023
DOI: 10.1111/srt.13377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin Research and Technology, 2023. Verfasst von Jenna Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Illinois-Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Nevus, Skin Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Melanoma Research Alliance.
Abstract (Originalsprache)
Introduction
Phacomatosis pigmentokeratotica (PPK), an epidermal nevus syndrome, is characterized by the coexistence of nevus spilus and nevus sebaceus. Within the nevus spilus, an extensive range of atypical nevi of different morphologies may manifest. Pigmented lesions may fulfill the ABCDE criteria for melanoma, which may prompt a physician to perform a full‐thickness biopsy. Motivation Excisions result in pain, mental distress, and physical disfigurement. For patients with a significant number of nevi with morphologic atypia, it may not be physically feasible to biopsy a large number of lesions. Optical coherence tomography (OCT) is a non‐invasive imaging modality that may be used to visualize non‐melanoma and melanoma skin cancers. Materials and Method In this study, we used OCT to image pigmented lesions with morphologic atypia in a patient with PPK and assessed their quantitative optical properties compared to OCT cases of melanoma. We implement a support vector machine learning algorithm with Gabor wavelet transformation algorithm during post‐image processing to extract optical properties and calculate attenuation coefficients.
Results
The algorithm was trained and tested to extract and classify textural data.
Conclusion
We conclude that implementing this post‐imaging machine learning algorithm to OCT images of pigmented lesions in PPK has been able to successfully confirm benign optical properties. Additionally, we identified remarkable differences in attenuation coefficient values and tissue optical characteristics, further defining separating benign features of pigmented lesions in PPK from malignant features.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, University of Illinois-Chicago, Chicago, Illinois, USA.
- Center for Cognitive Science, Institute for Convergence Science and Technology (ICST), Sharif University of Technology, Tehran, Islamic Republic of Iran.
- Department of Computer Engineering, Shahid Rajaee Teacher Training University, Tehran, Islamic Republic of Iran.
- School of Cognitive Sciences, Institute for Research in Fundamental Sciences (IPM), Tehran, Islamic Republic of Iran.
- Department of Biomedical Engineering, University of Illinois-Chicago, Chicago, Illinois, USA.
Förderung
- Melanoma Research Alliance
Zitieren
APA
Lee, J., Beirami, M. J., Ebrahimpour, R., Puyana, C., Tsoukas, M., & Avanaki, K. (2023). Optical coherence tomography confirms non‐malignant pigmented lesions in phacomatosis pigmentokeratotica using a support vector machine learning algorithm. Skin Research and Technology. https://doi.org/10.1111/srt.13377
Vancouver
Lee J, Beirami MJ, Ebrahimpour R, Puyana C, Tsoukas M, Avanaki K. Optical coherence tomography confirms non‐malignant pigmented lesions in phacomatosis pigmentokeratotica using a support vector machine learning algorithm. Skin Research and Technology. 2023. doi:10.1111/srt.13377
BibTeX
@article{Lee2023,
author = {Lee, Jenna and Beirami, Mohammad Javad and Ebrahimpour, Reza and Puyana, Carolina and Tsoukas, Maria and Avanaki, Kamran},
title = {Optical coherence tomography confirms non‐malignant pigmented lesions in phacomatosis pigmentokeratotica using a support vector machine learning algorithm},
journal = {Skin Research and Technology},
year = {2023},
doi = {10.1111/srt.13377}
}
EUVIMED